Orthopedic Company Comes Under SEC Scrutiny

Law360, New York (November 21, 2006, 12:00 AM EST) -- Orthopedic products company ReGen Biologics Inc. said Monday that it has received a letter from the U.S. Securities and Exchange Commission’s Division of Enforcement requesting information regarding the company’s stock options-granting practices.

The investigation, disclosed in the company latest filing with the SEC, comes in the wake of the company restating past financial results.

ReGen said the SEC’s Nov. 16 letter requested “that the company preserve all documents concerning its granting of stock options to any of its executives or employees from January 2002 through the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.